BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long CovidGlobe Newswire•14/09/2026•20:010 ShareWhiz InsightsGenerateNo content available.
